Q2 2021 Holdings
Filed 2021-08-16 | 72 holdings | $310.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $117.5M | 339,300 | 37.9% |
| Align Technology Inc(ALGN) | COM | 016255101 | $72.6M | 118,780 | 23.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $51.8M | 1,210,570 | 16.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $51.4M | 3,248,100 | 16.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.8M | 749,310 | 4.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $122.9K | 764,330 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $115.7K | 1,235,048 | 0.0% |
| Petco Health & Wellness Co I(WOOF) | COM | 71601V105 | $110.8K | 4,944,450 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $106.3K | 190,380 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $105.8K | 239,030 | 0.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $105.7K | 1,267,330 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $103.3K | 384,920 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $98.5K | 1,474,370 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $92.3K | 182,970 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $89.7K | 789,658 | 0.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $82.3K | 1,055,316 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $74.6K | 600,720 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $71.0K | 273,190 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $62.4K | 376,330 | 0.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $52.4K | 1,255,597 | 0.0% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $50.4K | 1,165,860 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $47.7K | 325,577 | 0.0% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $42.7K | 229,170 | 0.0% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $42.3K | 136,080 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $38.6K | 158,280 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $38.0K | 389,980 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $37.7K | 187,000 | 0.0% |
| Welltower Inc(WELL) | COM | 95040Q104 | $36.1K | 434,590 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $35.1K | 169,710 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $30.7K | 160,760 | 0.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $30.3K | 264,340 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $30.1K | 1,751,342 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $29.5K | 649,052 | 0.0% |
| Ventas Inc(VTR) | COM | 92276F100 | $28.0K | 489,640 | 0.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $25.2K | 376,180 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $23.8K | 117,960 | 0.0% |
| Incyte Corp(INCY)Call | COM | 45337C102 | $22.5K | 267,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $21.7K | 50,890 | 0.0% |
| Longview Acquisition Corp II | COM CL A | 54319Q105 | $20.9K | 2,135,900 | 0.0% |
| Affimed N V | COM | N01045108 | $20.6K | 2,422,964 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $18.9K | 29,900 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $14.1K | 386,190 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $13.4K | 1,324,800 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $13.3K | 1,238,881 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $10.5K | 125,000 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $7.2K | 744,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $6.7K | 522,712 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $6.4K | 200,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $5.4K | 250,000 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $5.3K | 377,551 | 0.0% |